Related Experiment Videos
An improved method for examination of cerebrospinal fluid cells
Neurology
|October 1, 1975
Summary
A novel cerebrospinal fluid (CSF) collection method preserves cell integrity for up to two weeks. This technique aids in analyzing CSF cytology for diagnosing neurologic diseases, even with low cell counts.
Area of Science:
- Neurology
- Cytopathology
- Biochemistry
Background:
- Cytologic examination of cerebrospinal fluid (CSF) is crucial for diagnosing neurological conditions.
- Traditional CSF sample handling can lead to cell degradation and loss of morphologic detail, limiting diagnostic accuracy.
- A need exists for improved CSF collection and preservation techniques.
Purpose of the Study:
- To introduce and evaluate a new method for collecting and preserving cerebrospinal fluid (CSF) for cytologic examination.
- To assess the preservation of cell count and morphologic detail in CSF samples collected using the new technique over an extended period.
- To compare CSF cell content between patients undergoing spinal anesthesia and those having myelography.
Main Methods:
- Cerebrospinal fluid (CSF) was collected directly from lumbar puncture needles into a Carbowax in ethanol solution.
- Samples were subsequently processed using a cytocentrifuge for cytologic analysis.
- Two patient cohorts were studied: those receiving spinal anesthesia and those undergoing myelography for low back pain.
Main Results:
- The new collection technique successfully preserved cells and morphologic detail in CSF samples for up to two weeks.
- Lymphocytes, polymorphonuclear neutrophils, and ependymal cells were consistently identified in CSF samples.
- Significant differences in the quantity and types of cells were observed between the spinal anesthesia and myelography patient groups.
Conclusions:
- The described Carbowax-ethanol fixation method offers a reliable approach for preserving CSF cytology for extended periods.
- This technique may enhance the sensitivity of CSF cytologic analysis, potentially aiding in the diagnosis of neurological diseases characterized by low cell counts.
- The method facilitates differentiation between patient groups based on CSF cellular profiles.